SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Kuo-Chin Chang, Po-Lin Tseng, Yi-Ying Wu, Hung-Chao Hung, Chao-Min Huang, Sheng-Nan Lu, Jing-Houng Wang, Chuan-Mo Lee, Chien-Hung Chen, Ming-Chao Tsai, Yi-Hao Yen, Ming-Tsung Lin, Cheng-Kun Wu, Chao-Cheng Huang, Hsiu-Hsi Chen, Tsung-Hui Hu, A Polymorphism in Interferon L3 Is an Independent Risk Factor for Development of Hepatocellular Carcinoma After Treatment of Hepatitis C Virus Infection, Clinical Gastroenterology and Hepatology, 2015, 13, 5, 1017

    CrossRef

  2. 2
    Savino Bruno, Alex J. Thompson, Rosina Critelli, Andrea Crosignani, Sonia Rossi, Stefania De Lisi, Elisabetta Cariani, Paola Zermiani, Valentina Vaira, Vincenzo Boccaccio, Patrick Maisonneuve, Erica Villa, Interferon lambda-3 is not associated with clinical outcome in patients with HCV-induced compensated cirrhosis: A long-term cohort study, Antiviral Research, 2015, 113, 27

    CrossRef

  3. 3
    Mohammed Eslam, Ahmed M. Hashem, Reynold Leung, Manuel Romero-Gomez, Thomas Berg, Gregory J. Dore, Henry L.K. Chan, William L. Irving, David Sheridan, Maria L. Abate, Leon A. Adams, Alessandra Mangia, Martin Weltman, Elisabetta Bugianesi, Ulrich Spengler, Olfat Shaker, Janett Fischer, Lindsay Mollison, Wendy Cheng, Elizabeth Powell, Jacob Nattermann, Stephen Riordan, Duncan McLeod, Nicola J. Armstrong, Mark W. Douglas, Christopher Liddle, David R. Booth, Jacob George, Golo Ahlenstiel, Javier Ampuero, Margaret Bassendine, Vincent W. S. Wong, Chiara Rosso, Rose White, Lavinia Mezzabotta, Vijayaprakash Suppiah, Monika Michalk, Barbara Malik, Gail Matthews, Tanya Applegate, Jason Grebely, Vincenzo Fragomeli, Julie R. Jonsson, Rosanna Santaro, Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease, Nature Communications, 2015, 6, 6422

    CrossRef

  4. 4
    Leonardo Mottola, Giovanni Cenderello, Valeria A. Piazzolla, Paolo Forte, Vito Carretta, Fabrizio Mecenate, Giuseppina Brancaccio, Rosalba Minisini, Massimo Zuin, Natalia Terreni, Monica Monti, Alberto Eraldo Colombo, Lorenzo Nosotti, Nicola Minerva, Ilaria Luzzitelli, Alba Kostandini, Giuseppe Cuccorese, Maurizio Russello, Rosanna Santoro, Alessandra Mangia, Interleukin-28B genetic variants in untreated Italian HCV-infected patients: a multicentre study, Liver International, 2015, 35, 2
  5. 5
    Normeen Hany Rady, Rania Kamal Darwish, Engy Adel Mogahed, Iman Atef Mandour, Hazem Abo Youssef, Sahar Abdel Atty Sharaf, Hanaa Mostafa El-Karaksy, Potential genetic markers for prediction of treatment response in Egyptian children infected with HCV genotype 4, Cytokine, 2015,

    CrossRef

  6. 6
    Luis M. Real, Antonio Caruz, Antonio Rivero-Juarez, Vicente Soriano, Karin Neukam, Antonio Rivero, Celia Cifuentes, José A. Mira, Juan Macías, Juan A. Pineda, A polymorphism linked to RRAS,SCAF1,IRF3 and BCL2L12 genes is associated with cirrhosis in hepatitis C virus carriers, Liver International, 2014, 34, 4
  7. 7
    Samar Samir Youssef, Eman Abd El-Razek Abbas, Asmaa Mostafa Abd el Aal, Taher el Zanaty, Sameh Mohamed Seif, Association ofIL28BPolymorphism with Fibrosis, Liver Inflammation, Gender Respective Natural History of Hepatitis C Virus in Egyptian Patients with Genotype 4, Journal of Interferon & Cytokine Research, 2014, 34, 1, 22

    CrossRef

  8. 8
    Yasuhiro Asahina, Kaoru Tsuchiya, Takashi Nishimura, Masaru Muraoka, Yuichiro Suzuki, Nobuharu Tamaki, Yutaka Yasui, Takanori Hosokawa, Ken Ueda, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Masayuki Kurosaki, Nobuyuki Enomoto, Mina Nakagawa, Sei Kakinuma, Mamoru Watanabe, Namiki Izumi, Genetic variation near interleukin 28B and the risk of hepatocellular carcinoma in patients with chronic hepatitis C, Journal of Gastroenterology, 2014, 49, 7, 1152

    CrossRef

  9. 9
    Q. Zhang, M. Lapalus, T. Asselah, C. Laouénan, R. Moucari, M. Martinot-Peignoux, I. Bieche, E. Estrabaud, S. De Muynck, N. Boyer, P. Bedossa, M. Vidaud, P. Marcellin, O. Lada, IFNL3 (IL28B) polymorphism does not predict long-term response to interferon therapy in HBeAg-positive chronic hepatitis B patients, Journal of Viral Hepatitis, 2014, 21, 7
  10. 10
    Abdel-Rahman N. Zekri, Hosny Salama, Eman Medhat, Abeer A. Bahnassy, Heba M. Morsy, Mai M. Lotfy, Rasha Ahmed, Tarneem Darwish, Mohamad S. Marei, IL28B rs12979860 Gene Polymorphism in Egyptian Patients with Chronic Liver Disease Infected with HCV, Asian Pacific Journal of Cancer Prevention, 2014, 15, 17, 7213

    CrossRef

  11. 11
    Kohei Oda, Hirofumi Uto, Kotaro Kumagai, Akio Ido, Kazunori Kusumoto, Kazuya Shimoda, Katsuhiro Hayashi, Sherri O. Stuver, Yasuhito Tanaka, Nao Nishida, Katsushi Tokunaga, Hirohito Tsubouchi, Impact of a single nucleotide polymorphism upstream of the IL28B gene in patients positive for anti-HCV antibody in an HCV hyperendemic area in Japan, Journal of Medical Virology, 2014, 86, 11
  12. 12
    Conrado M. Fernández Rodriguez, Maria Luisa Gutierrez Garcia, Impacto del tratamiento antiviral en la historia natural del virus de la hepatitis C, Gastroenterología y Hepatología, 2014, 37, 10, 583

    CrossRef

  13. 13
    M. E. Mancuso, S. Linari, A. Aghemo, D. Bartolozzi, E. Santagostino, M. G. Rumi, E. Fognani, M. R. Fasulo, L. Gragnani, R. Bruno, M. Morfini, A. L. Zignego, M. Colombo, Interferon lambda 3 rs12979860 polymorphism in patients with haemophilia and HCV infection: a predictor of spontaneous viral clearance and sustained virological response, Thrombosis and Haemostasis, 2014, 111, 6, 1067

    CrossRef

  14. 14
    Matthew T Kitson, Jacob George, Gregory J Dore, Reynold Leung, Peter Button, Geoffrey W McCaughan, Darrell H G Crawford, William Sievert, Martin D Weltman, Wendy S C Cheng, Stuart K Roberts, Interleukin-28B rs12979860 C allele: Protective against advanced fibrosis in chronic hepatitis C genotype 1 infection, Journal of Gastroenterology and Hepatology, 2014, 29, 7
  15. 15
    E. Jouvin-Marche, Z. Macek Jilkova, M.-A. Thelu, H. Marche, E. Fugier, N. Van Campenhout, X. S. Hoang, A. Marlu, N. Sturm, M. Callanan, V. Leroy, J.-P. Zarski, P. N. Marche, Lymphocytes Degranulation in Liver in Hepatitis C Virus Carriers Is Associated With IFNL4 Polymorphisms and ALT Levels, Journal of Infectious Diseases, 2014, 209, 12, 1907

    CrossRef

  16. 16
    Eleonora Grassi, Alessio Aghemo, Massimo Colombo, Optimal Management of Hepatitis C Genotype 2 Chronic Infection, Current Hepatology Reports, 2014, 13, 4, 273

    CrossRef

  17. 17
    Maria Antonella Burza, Antonio Molinaro, Maria Luisa Attilia, Claudia Rotondo, Fabio Attilia, Mauro Ceccanti, Flaminia Ferri, Federica Maldarelli, Angela Maffongelli, Adriano Santis, Adolfo Francesco Attili, Stefano Romeo, Stefano Ginanni Corradini, PNPLA3 I148M (rs738409) genetic variant and age at onset of at-risk alcohol consumption are independent risk factors for alcoholic cirrhosis, Liver International, 2014, 34, 4
  18. 18
    Claudio Zavaglia, Enrico Silini, Alessandra Mangia, Aldo Airoldi, Valeria Piazzolla, Marcello Vangeli, Rosa Stigliano, Antonella Foschi, Chiara Mazzarelli, Carmine Tinelli, Prognostic factors of hepatic decompensation and hepatocellular carcinoma in patients with transfusion-acquired HCV infection, Liver International, 2014, 34, 7
  19. 19
    Kentaro Matsuura, Tsunamasa Watanabe, Yasuhito Tanaka, Role of IL28B for chronic hepatitis C treatment toward personalized medicine, Journal of Gastroenterology and Hepatology, 2014, 29, 2
  20. 20
    Simone Regina Souza da Silva Conde, Julius Caesar Mendes Soares Monteiro, Bruna Tereza Silva dos Santos, Nathália Karla Fonseca Filgueiras, Pedro Alves de Almeida Lins, Felipe Bonfim Freitas, Ednelza da Silva Graça, Sâmia Demachki, Marialva Tereza Ferreira de Araújo, Ricardo Ishak, Antonio Carlos Rosário Vallinoto, SNP rs8099917 in Gene IL28B Might Be Associated with Risk of Chronic Infection by HCV but Not with Response to Treatment, BioMed Research International, 2014, 2014, 1

    CrossRef

  21. 21
    Mazen Noureddin, Elizabeth C. Wright, Harvey J. Alter, Shauna Clark, Emmanuel Thomas, Richard Chen, Xiongce Zhao, Cathy Conry-Cantilena, David E. Kleiner, T. Jake Liang, Marc G. Ghany, Association of IL28B genotype with fibrosis progression and clinical outcomes in patients with chronic hepatitis C: A longitudinal analysis, Hepatology, 2013, 58, 5
  22. 22
    Rajagopal N. Aravalli, Erik N. K. Cressman, Clifford J. Steer, Cellular and molecular mechanisms of hepatocellular carcinoma: an update, Archives of Toxicology, 2013, 87, 2, 227

    CrossRef

  23. 23
    Alessio Aghemo, Elisabetta Degasperi, Maria Grazia Rumi, Enrico Galmozzi, Luca Valenti, Raffaele De Francesco, Stella De Nicola, Cristina Cheroni, Eleonora Grassi, Massimo Colombo, Cirrhosis and Rapid Virological Response to Peginterferon Plus Ribavirin Determine Treatment Outcome in HCV-1 IL28B rs12979860 CC Patients, BioMed Research International, 2013, 2013, 1

    CrossRef

  24. 24
    Scott W. Biggins, James Trotter, Jane Gralla, James R. Burton, Kiran M. Bambha, Jennifer Dodge, Megan Brocato, Linling Cheng, Matt McQueen, Lisa Forman, Michael Chang, Igal Kam, Gregory Everson, Richard A. Spritz, Goran Klintmalm, Hugo R. Rosen, Differential effects of donor and recipient IL28B and DDX58 SNPs on severity of HCV after liver transplantation, Journal of Hepatology, 2013, 58, 5, 969

    CrossRef

  25. You have free access to this content25
    Y. Maor, G. Morali, D. Bashari, G. Pénaranda, J. M. Schapiro, U. Martinowitz, P. Halfon, Genetic polymorphism of IL28B in hepatitis C-infected haemophilia patients in Israel, Haemophilia, 2013, 19, 1
  26. You have free access to this content26
    Eleonora Grassi, Alessio Aghemo, How to optimize HCV therapy in genotype 2 patients, Liver International, 2013, 33,
  27. 27
    Chen-Hua Liu, Jia-Horng Kao, IL28B Genotype on HCV Infection in Asia, Current Hepatitis Reports, 2013, 12, 3, 149

    CrossRef

  28. 28
    María Guzmán-Fulgencio, Juan Berenguer, Mónica García-Álvarez, Amanda Fernández-Rodríguez, María A. Jiménez-Sousa, Emilio Álvarez, Dariela Micheloud, Juan Carlos López, Pilar Miralles, Jaime Cosín, Pilar Catalán, Salvador Resino, IL28B polymorphisms are associated with severity of liver disease in human immunodeficiency virus (HIV) patients coinfected with hepatitis C virus, Journal of Infection, 2013, 66, 2, 170

    CrossRef

  29. 29
    Concha de la Fuente, Carmen Hinojosa, Isabel Gilabert, Maria Ángeles Jiménez Sousa, Jose Manuel González, Raúl Ortiz de Lejarazu, Ana Loma, Concepción Nieto, Rosa Arnaiz, Jesús F. Bermejo-Martin, Interleukin 28B rs12979860 (CT/TT) Genotype Is Associated with Milder Hepatic Damage in the Natural Evolution of HCV/HIV Coinfection, Journal of Interferon & Cytokine Research, 2013, 33, 1, 43

    CrossRef

  30. 30
    Adriaan J. Meer, Raoel Maan, Robert J. Knegt, Bart J. Veldt, Natural History of HCV-induced Liver Disease, Current Hepatitis Reports, 2013, 12, 4, 251

    CrossRef

  31. 31
    Salvatore Petta, Antonio Craxi, Reply to: “IL28B rs12979860 is not associated with histologic features of NAFLD in a cohort of Caucasian North American patients”, Journal of Hepatology, 2013, 58, 2, 403

    CrossRef

  32. 32
    Marwa Khairy, Rabab Fouad, Mahassen Mabrouk, Wafaa El-Akel, Abu Bakr Awad, Rabab Salama, Mayada Elnegouly, Olfat Shaker, The Impact of Interleukin 28b Gene Polymorphism on the Virological Response to Combined Pegylated Interferon and Ribavirin Therapy in Chronic HCV Genotype 4 Infected Egyptian Patients Using Data Mining Analysis, Hepatitis Monthly, 2013, 13, 6

    CrossRef

  33. 33
    Mauro Viganò, Elisabetta Degasperi, Alessio Aghemo, Pietro Lampertico, Massimo Colombo, Anti-TNF drugs in patients with hepatitis B or C virus infection: safety and clinical management, Expert Opinion on Biological Therapy, 2012, 12, 2, 193

    CrossRef

  34. 34
    Satoru Joshita, Takeji Umemura, Yoshihiko Katsuyama, Yuki Ichikawa, Takefumi Kimura, Susumu Morita, Atsushi Kamijo, Michiharu Komatsu, Tetsuya Ichijo, Akihiro Matsumoto, Kaname Yoshizawa, Nozomi Kamijo, Masao Ota, Eiji Tanaka, Association of IL28B gene polymorphism with development of hepatocellular carcinoma in Japanese patients with chronic hepatitis C virus infection, Human Immunology, 2012, 73, 3, 298

    CrossRef

  35. 35
    Jacinta A. Holmes, Alexander J. Thompson, Leon A. Adams, Biomarkers of Fibrosis and Fibrosis Progression in Chronic Hepatitis C, Current Hepatitis Reports, 2012, 11, 4, 231

    CrossRef

  36. 36
    Klára Werling, Károly Rácz, Gene polymorphisms in chronic C virus hepatitis, Interventional Medicine and Applied Science, 2012, 4, 2, 69

    CrossRef

  37. 37
    Miyuki Miyashita, Takayoshi Ito, Masashi Sakaki, Atsushi Kajiwara, Hisako Nozawa, Kazumasa Hiroishi, Mariko Kobayashi, Hiromitsu Kumada, Michio Imawari, Genetic polymorphism in cyclooxygenase-2 promoter affects hepatic inflammation and fibrosis in patients with chronic hepatitis C, Journal of Viral Hepatitis, 2012, 19, 9
  38. 38
    C. Nelson Hayes, Michio Imamura, Hiroshi Aikata, Kazuaki Chayama, Genetics of IL28B and HCV—response to infection and treatment, Nature Reviews Gastroenterology & Hepatology, 2012, 9, 7, 406

    CrossRef

  39. 39
    Emilie Estrabaud, Michel Vidaud, Patrick Marcellin, Tarik Asselah, Genomics and HCV infection: Progression of fibrosis and treatment response, Journal of Hepatology, 2012, 57, 5, 1110

    CrossRef

  40. 40
    Monika Rau, Katharina Baur, Andreas Geier, Host Genetic Variants in the Pathogenesis of Hepatitis C, Viruses, 2012, 4, 12, 3281

    CrossRef

  41. 41
    Paul J Clark, Alexander J Thompson, Host genomics and HCV treatment response, Journal of Gastroenterology and Hepatology, 2012, 27, 2
  42. 42
    Pierre-Yves Bochud, Stéphanie Bibert, Zoltán Kutalik, Etienne Patin, Julien Guergnon, Bertrand Nalpas, Nicolas Goossens, Lorenz Kuske, Beat Müllhaupt, Tillman Gerlach, Markus H. Heim, Darius Moradpour, Andreas Cerny, Raffaele Malinverni, Stephan Regenass, Guenter Dollenmaier, Hans Hirsch, Gladys Martinetti, Meri Gorgiewski, Marc Bourlière, Thierry Poynard, Ioannis Theodorou, Laurent Abel, Stanislas Pol, Jean-François Dufour, Francesco Negro, IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes, Hepatology, 2012, 55, 2
  43. 43
    Salvatore Petta, Stefania Grimaudo, Calogero Cammà, Daniela Cabibi, Vito Di Marco, Giusalba Licata, Rosaria Maria Pipitone, Antonio Craxì, IL28B and PNPLA3 polymorphisms affect histological liver damage in patients with non-alcoholic fatty liver disease, Journal of Hepatology, 2012, 56, 6, 1356

    CrossRef

  44. 44
    Luca Valenti, Edoardo Pulixi, Susanna La Spina, IL28B, HCV core mutations, and hepatocellular carcinoma: does host genetic make-up shape viral evolution in response to immunity?, Hepatology International, 2012, 6, 1, 356

    CrossRef

  45. 45
    L. Valenti, A. Aghemo, A. F. Stättermayer, P. Maggioni, S. Nicola, B. M. Motta, M. G. Rumi, P. Dongiovanni, P. Ferenci, M. Colombo, S. Fargion, Implications of PNPLA3 polymorphism in chronic hepatitis C patients receiving peginterferon plus ribavirin, Alimentary Pharmacology & Therapeutics, 2012, 35, 12
  46. 46
    Luca Valenti, Alessio Aghemo, Albert Friedrich Stättermayer, Interaction between IL28B and PNPLA3 genotypes in the pathogenesis of steatosis in chronic hepatitis C non genotype-3 patients, Journal of Hepatology, 2012, 56, 5, 1209

    CrossRef

  47. 47
    Nicholas A. Shackel, Looking into Pandora's box , Liver Transplantation, 2012, 18, 3
  48. 48
    Monika Sarkar, Peter Bacchetti, Audrey L. French, Phyllis Tien, Marshall J. Glesby, Marek Nowicki, Michael Plankey, Stephen Gange, Gerald Sharp, Howard Minkoff, Marion G. Peters, Lower liver-related death in African-American women with human immunodeficiency virus/hepatitis C virus coinfection, compared to Caucasian and Hispanic women, Hepatology, 2012, 56, 5
  49. 49
    Shiv K. Sarin, Manoj Kumar, Natural history of HCV infection, Hepatology International, 2012, 6, 4, 684

    CrossRef

  50. 50
    V. Soriano, E. Poveda, E. Vispo, P. Labarga, N. Rallon, P. Barreiro, Pharmacogenetics of hepatitis C, Journal of Antimicrobial Chemotherapy, 2012, 67, 3, 523

    CrossRef

  51. 51
    J. A. Mira, S. Garcia-Rey, A. Rivero, I. de los Santos-Gil, L. F. Lopez-Cortes, J. A. Giron-Gonzalez, F. Tellez, M. Marquez, D. Merino, M. J. Rios-Villegas, J. Macias, A. Rivero-Juarez, J. A. Pineda, Response to Pegylated Interferon Plus Ribavirin Among HIV/Hepatitis C Virus-Coinfected Patients With Compensated Liver Cirrhosis, Clinical Infectious Diseases, 2012, 55, 12, 1719

    CrossRef

  52. 52
    Tatsuo Miyamura, Tatsuo Kanda, Shingo Nakamoto, Shuang Wu, Xia Jiang, Makoto Arai, Keiichi Fujiwara, Fumio Imazeki, Osamu Yokosuka, Roles of ITPA and IL28B Genotypes in Chronic Hepatitis C Patients Treated with Peginterferon Plus Ribavirin, Viruses, 2012, 4, 12, 1264

    CrossRef

  53. 53
    Andres Duarte-Rojo, Bart J. Veldt, David D. Goldstein, Hans L. Tillman, Kymberly D. Watt, Julie K. Heimbach, John G. McHutchison, John J. Poterucha, Florencia Vargas-Vorackova, Michael R. Charlton, The Course of Posttransplant Hepatitis C Infection, Transplantation Journal, 2012, 94, 2, 197

    CrossRef

  54. 54
    Nicholas A Shackel, When has the horse bolted?, Journal of Gastroenterology and Hepatology, 2012, 27, 7